Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
Links shared publicly online about this topic.
- 137total visits
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
View full resource at drugs.com
Tags: IBD, Ulcerative Colitis, Ulcerative Colitis Medication, Lialda, Asacol, Pentasa, Ulcer, Colitis
Most Recently Shared on July 19, 2011 at 1:07 am By:
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis: Lialda has be... http://bit.ly/pKdIFe #drug
Lialda® (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis
medicalnewstoday.com — “Shire plc (LSE: SHP; NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Ta” View full resource at medicalnewstoday.com
Most Recently Shared on July 20, 2011 at 9:07 am By:
MNT Drug Approvals Health News
Lialda® (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis http://mnt.to/3YpB #regulatory
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
drugs.com — “Lialda (mesalamine) is used to treat ulcerative colitis. Information from Drugs.com includes Lialda side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 19, 2011 at 12:41 am By:
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis - http://bit.ly/rbWZJQ
Lialda(R) (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Rele” View full resource at medicalnewstoday.com
Most Recently Shared on July 18, 2011 at 4:05 pm By:
MNT Drug Approvals Health News
Lialda(R) (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis http://mnt.to/3YkK #regulatory
Advertisement
